These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 3260790)

  • 1. B and T cell reactivities after immunization of macaques with HIV subcomponents.
    Wahren B; Chiodi F; Ljunggren K; Putney S; Kurth R; Gallo RC; Fenyö EM
    AIDS Res Hum Retroviruses; 1988 Jun; 4(3):199-210. PubMed ID: 3260790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-cell responses to human AIDS virus in macaques immunized with recombinant vaccinia viruses.
    Zarling JM; Morton W; Moran PA; McClure J; Kosowski SG; Hu SL
    Nature; 1986 Sep 25-Oct 1; 323(6086):344-6. PubMed ID: 3093891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.
    Wahren B; Morfeldt-Månsson L; Biberfeld G; Moberg L; Sönnerborg A; Ljungman P; Werner A; Kurth R; Gallo R; Bolognesi D
    J Virol; 1987 Jun; 61(6):2017-23. PubMed ID: 3033328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolate- and group-specific immune responses to the envelope protein of human immunodeficiency virus induced by a live recombinant vaccinia virus in macaques.
    Earl PL; Robert-Guroff M; Matthews TJ; Krohn K; London WT; Moss B
    AIDS Res Hum Retroviruses; 1989 Feb; 5(1):23-32. PubMed ID: 2541747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular immune response to viral peptides in patients exposed to HIV.
    Ahearne PM; Matthews TJ; Lyerly HK; White GC; Bolognesi DP; Weinhold KJ
    AIDS Res Hum Retroviruses; 1988 Aug; 4(4):259-67. PubMed ID: 2462895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130.
    Voss G; Dittmer U; Coulibaly C; Makoschey B; Petry H; Lüke W; Hunsmann G
    J Gen Virol; 1993 Sep; 74 ( Pt 9)():1757-63. PubMed ID: 8376957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mimicking the humoral immune response in vitro results in antigen-specific isotype switching supported by specific autologous T helper cells: generation of human HIV-1-neutralizing IgG monoclonal antibodies from naive donors.
    Chin LT; Malmborg AC; Kristensson K; Hinkula J; Wahren B; Borrebaeck CA
    Eur J Immunol; 1995 Mar; 25(3):657-63. PubMed ID: 7535699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neutralizing antibodies to 5 HIV-1 strains in macaques immunized with the multi-epitope polypeptide TAB9].
    Navea Leyva LM; Lobaina Bartelemy L; Dubed Echevarría M; Alvarez Seguí G; Gómez Rodríguez C; Duarte Cano C
    Rev Cubana Med Trop; 2000; 52(2):115-8. PubMed ID: 11107905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of HIVMN neutralizing antibodies in primates using a prime-boost regimen of hybrid synthetic gp120 envelope peptides.
    Haynes BF; Torres JV; Langlois AJ; Bolognesi DP; Gardner MB; Palker TJ; Scearce RM; Jones DM; Moody MA; McDanal C
    J Immunol; 1993 Aug; 151(3):1646-53. PubMed ID: 8335949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses.
    Kumar A; Lifson JD; Silverstein PS; Jia F; Sheffer D; Li Z; Narayan O
    Virology; 2000 Aug; 274(1):149-64. PubMed ID: 10936096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1-infected patients with envelope-specific lymphoproliferation or long-term nonprogression lack antibodies suppressing glycoprotein 120 antigen presentation.
    Chien PC; Chen D; Chen PD; Tuen M; Cohen S; Migueles SA; Connors M; Rosenberg E; Malhotra U; Gonzalez C; Hioe CE
    J Infect Dis; 2004 Mar; 189(5):852-61. PubMed ID: 14976603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective mucosal immunity elicited by targeted lymph node immunization with a subunit SIV envelope and core vaccine in macaques.
    Lehner T; Wang Y; Cranage M; Bergmeier LA; Mitchell E; Tao L; Hall G; Dennis M; Cook N; Jones I; Doyle C
    Dev Biol Stand; 1998; 92():225-35. PubMed ID: 9554279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of HIV-specific antibody response and protection against vaginal SHIV transmission by intranasal immunization with inactivated SHIV-capturing nanospheres in macaques.
    Miyake A; Akagi T; Enose Y; Ueno M; Kawamura M; Horiuchi R; Hiraishi K; Adachi M; Serizawa T; Narayan O; Akashi M; Baba M; Hayami M
    J Med Virol; 2004 Jul; 73(3):368-77. PubMed ID: 15170630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccination of rhesus macaques with recombinant Mycobacterium bovis bacillus Calmette-Guérin Env V3 elicits neutralizing antibody-mediated protection against simian-human immunodeficiency virus with a homologous but not a heterologous V3 motif.
    Someya K; Cecilia D; Ami Y; Nakasone T; Matsuo K; Burda S; Yamamoto H; Yoshino N; Kaizu M; Ando S; Okuda K; Zolla-Pazner S; Yamazaki S; Yamamoto N; Honda M
    J Virol; 2005 Feb; 79(3):1452-62. PubMed ID: 15650171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing activity and cellular immune responses induced in mice after immunization with apoptotic HIV-1/murine leukemia virus infected cells.
    Hinkula J; Walther-Jallow L; Laurén A; Mäkitalo B; Oberg M; Wahren B; Fenyö EM; Spetz AL
    Vaccine; 2009 Oct; 27(46):6424-31. PubMed ID: 19549607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.
    Rollman E; Hinkula J; Arteaga J; Zuber B; Kjerrström A; Liu M; Wahren B; Ljungberg K
    Gene Ther; 2004 Jul; 11(14):1146-54. PubMed ID: 15103320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzyme immunoassay using a novel recombinant polypeptide to detect human immunodeficiency virus env antibody.
    Thorn RM; Beltz GA; Hung CH; Fallis BF; Winkle S; Cheng KL; Marciani DJ
    J Clin Microbiol; 1987 Jul; 25(7):1207-12. PubMed ID: 3475281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.